Boyce E. Griffith

Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense

Efficacy of Clarithromycin and Ethambutol for Mycobacterium avium Complex Pulmonary Disease. A Preliminary Study

Pulmonary Disease Due to Nontuberculous Mycobacteria

Long-term Follow-up of Mycobacterium avium Complex Lung Disease in Patients Treated With Regimens Including Clofazimine and/or Rifampin

Aerosolized amikacin for treatment of pulmonary Mycobacterium aviuminfections: an observational case series

Bioprosthetic Valve Thrombosis

Treatment of Mycobacterium avium-intracellulare complex Lung Disease With a Macrolide, Ethambutol, and Clofazimine

Effects of extracellular matrix viscoelasticity on cellular behaviour

British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)

Repeat Positive Cultures inMycobacterium intracellulareLung Disease after Macrolide Therapy Represent New Infections in Patients with Nodular Bronchiectasis

Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease

The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease

Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary

Mycobacterium avium complex Pulmonary Disease in Patients Without HIV Infection

Fluid Dynamics of Heart Development

A viscoelastic adhesive epicardial patch for treating myocardial infarction

Clinical and Molecular Analysis of Macrolide Resistance in Mycobacterium avium Complex Lung Disease

An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases

Ethambutol Ocular Toxicity in Treatment Regimens for Mycobacterium avium Complex Lung Disease

Semiquantitative Culture Analysis during Therapy for Mycobacterium avium Complex Lung Disease

Intermittent Antibiotic Therapy for Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease

A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013

Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America

Computer Simulation of Liquids

Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria

Piezo1, a mechanically activated ion channel, is required for vascular development in mice

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Infection Source and Epidemiology of Nontuberculous Mycobacterial Lung Disease

Standardized Combination Antibiotic Treatment ofMycobacterium aviumComplex Lung Disease

Lattice-Boltzmann Method for Complex Flows

Azithromycin-Containing Regimens for Treatment of Mycobacterium avium Complex Lung Disease

Emerging Trends in Heart Valve Engineering: Part II. Novel and Standard Technologies for Aortic Valve Replacement

Dynamic finite-strain modelling of the human left ventricle in health and disease using an immersed boundary-finite element method

The immersed boundary method for advection–electrodiffusion with implicit timestepping and local mesh refinement

On the order of accuracy of the immersed boundary method: Higher order convergence rates for sufficiently smooth problems

Structure‐based finite strain modelling of the human left ventricle in diastole